GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Vectus Biosystems Ltd (ASX:VBS) » Definitions » Long-Term Capital Lease Obligation

Vectus Biosystems (ASX:VBS) Long-Term Capital Lease Obligation : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Vectus Biosystems Long-Term Capital Lease Obligation?

Vectus Biosystems's Long-Term Capital Lease Obligation for the quarter that ended in Dec. 2024 was A$0.00 Mil.

Vectus Biosystems's annual Long-Term Capital Lease Obligation declined from Jun. 2022 (A$0.07 Mil) to Jun. 2023 (A$0.03 Mil) and declined from Jun. 2023 (A$0.03 Mil) to Jun. 2024 (A$0.00 Mil).


Vectus Biosystems Long-Term Capital Lease Obligation Historical Data

The historical data trend for Vectus Biosystems's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vectus Biosystems Long-Term Capital Lease Obligation Chart

Vectus Biosystems Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only 0.04 0.02 0.07 0.03 -

Vectus Biosystems Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.03 - - -

Vectus Biosystems  (ASX:VBS) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Vectus Biosystems Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Vectus Biosystems's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Vectus Biosystems Business Description

Industry
Traded in Other Exchanges
N/A
Address
26-34 Dunning Avenue, Unit 5, Ground Floor, Rosebery, Sydney, NSW, AUS, 2018
Vectus Biosystems Ltd is an emerging biotechnology company based in Sydney, Australia. The company has developed and patented various novel compounds for the treatment of chronic fibrosis, including heart, kidney, liver, and lung fibrosis. Its drug candidate VB0004, is aimed at inhibiting and reversing the loss of functional tissue due to fibrosis, is in its human trials phase. The company has also developed a technology aimed at improving the speed and accuracy of measuring the amount of DNA and RNA in samples tested in laboratories. It operates in one segment, being pharmaceutical research and development.

Vectus Biosystems Headlines

No Headlines